Authorize pharmacists to test, treat certain health conditions

Added explicit authorization for pharmacists to screen, test, and treat patients for influenza, group A streptococcus pharyngitis, and COVID-19.

Mandated that sickness and accident insurers and public employee benefit plans must reimburse pharmacists for these services if their policies cover equivalent services from other providers.

Required the State Board of Pharmacy to develop a statewide written protocol for these screenings and treatments, including rules for patient history, treatment criteria, and referrals.

Established a review process where the State Medical Board can comment on the screening protocol before it is finalized.

Expanded the definition of 'Prescription' to include specific orders for epinephrine autoinjectors and glucagon issued to schools and camps.

Added new definitions for various entities such as 'animal shelter,' 'wild animal rehabilitation facility,' 'outsourcing facility,' and 'repackager of dangerous drugs'.